Literature DB >> 12462565

Neutrophil modulation of the pulmonary chemokine response to lipopolysaccharide.

Michael C Holmes1, Ping Zhang, Steve Nelson, Warren R Summer, Gregory J Bagby.   

Abstract

When cells within the intrapulmonary compartment are exposed to pathogens or their products such as lipopolysaccharide, they produce CXC chemokines in order to attract circulating neutrophils into the lower respiratory tract. Previous studies have shown that as neutrophils (PMNs) enter the lung, bronchoalveolar lavage (BAL) chemokine levels are decreased. In this study, we determined the intrapulmonary and systemic responses to two important rat chemokines, cytokine-induced neutrophil chemoattractant (CINC) and macrophage inflammatory protein-2 (MIP-2), to intratracheal (i.t.) LPS (100 microg in 0.5 mL of phosphate-buffered saline) under neutropenic (cyclophosphamide [CPA]) and neutrophilic (G-CSF) conditions. By 4 h after i.t. LPS, CPA pretreatment decreased PMN recruitment 83% and G-CSF increased PMN recruitment 91% compared with recruitment into the lung in vehicle-pretreated rats (42.7 +/- 19.3 million PMNs). Neutropenic rats had increased CINC and MIP-2 concentrations in BAL fluid 4 h after i.t. LPS when compared with levels seen in vehicle controls (P < 0.05). In vitro LPS-stimulated chemokine production by alveolar macrophages obtained from CPA- and vehicle-pretreated animals did not differ. The increase in BAL fluid chemokine levels in neutropenic rats corresponded to increased chemotaxis of neutrophils to BAL fluid from CPA-pretreated rats as compared with the chemotaxis response of PMN to BAL fluid from vehicle-pretreated rats. In contrast, G-CSF enhancement of neutrophil recruitment decreased chemotactic activity of BAL fluid collected 4 h after i.t. LPS. These data show that as neutrophils are recruited into the lung, they alter chemokine levels, which most likely serves to down-regulate the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462565     DOI: 10.1097/00024382-200212000-00012

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Proinflammatory cytokine surge after injury stimulates an airway immunoglobulin a increase.

Authors:  Mark A Jonker; Yoshifumi Sano; Joshua L Hermsen; Jinggang Lan; Kenneth A Kudsk
Journal:  J Trauma       Date:  2010-10

2.  Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling.

Authors:  Meghan L Lindauer; John Wong; Yoichiro Iwakura; Bruce E Magun
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

3.  Relationship of acute lung inflammatory injury to Fas/FasL system.

Authors:  Thomas A Neff; Ren-Feng Guo; Simona B Neff; J Vidya Sarma; Cecilia L Speyer; Hongwei Gao; Kurt D Bernacki; Markus Huber-Lang; Stephanie McGuire; L Marco Hoesel; Niels C Riedemann; Beatrice Beck-Schimmer; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

4.  Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor.

Authors:  Nathan M Blackwell; Phupinder Sembi; Justine S Newson; Toby Lawrence; Derek W Gilroy; Panagiotis S Kabouridis
Journal:  Arthritis Rheum       Date:  2004-08

5.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

7.  Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis.

Authors:  Christian Østergaard; Terence O'Reilly; Christian Brandt; Niels Frimodt-Møller; Jens D Lundgren
Journal:  BMC Infect Dis       Date:  2006-04-27       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.